Author:
Ren Jingming,Huang Rong,Li Yanjie,Chen Ruiyang,Tian Hongqi,Liu Chenlu
Abstract
AbstractIonizing radiation (IR) can cause damage to the structure and function of salivary glands. Our research group independently synthesized the ROS scavenger, HL-003. The aim of this study was to explore the protective effects and underlying mechanisms of HL-003 on radiation-induced salivary gland injury. Salivary flow rate measurement, H&E staining, immunohistochemistry, FRAP, TUNEL, and western blotting were used to evaluate the radioprotective effect on salivary glands. The results showed that HL-003 protected the salivary secretion function by protecting the AQP-5 protein, on the salivary epithelial cell membrane, from IR damage. HL-003 reduced oxidative stress in the salivary gland by regulating the expression of ROS-related proteins NOX4, SOD2, and 8-OHdG. Furthermore, HL-003 downregulated the expression of p-p53, Bax, caspase 3, and caspase 9, and upregulated the expression of Bcl-2, suggesting that it could inhibit the activation of p53 to reduce cell apoptosis. In conclusion, HL-003 is an effective radioprotector that prevents damage of the radiation-induced salivary gland.
Funder
the Technological Support Projects of the Tianjin Key R&D Program.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Huang, G. & Pan, S. T. ROS-mediated therapeutic strategy in chemo-/radiotherapy of head and neck cancer. Oxid. Med. Cell Longev. 2020, 30 (2020).
2. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
3. Qiu, H., Cao, S. & Xu, R. Cancer incidence, mortality, and burden in China: A time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. 41, 1037–1048 (2021).
4. Jasmer, K. J., Gilman, K. E., Munoz Forti, K., Weisman, G. A. & Limesand, K. H. Radiation-induced salivary gland dysfunction: Mechanisms, therapeutics and future directions. J. Clin. Med. 9, 4095 (2020).
5. Porter, S. R., Fedele, S. & Habbab, K. M. Xerostomia in head and neck malignancy. Oral Oncol. 46, 460–463 (2010).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献